Institutional investors purchased a net $2.2 million shares of ANTH during the quarter ended December 2016, and now own 50.88% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABBY CAPITAL LLC Bought 6.4 Million shares of Anthera Pharmaceuticals I...